Dr Reddys Valuation
| RDY Stock | USD 14.30 0.16 1.13% |
At this time, the firm appears to be fairly valued. Dr Reddys Laboratories owns a latest Real Value of $14.67 per share. The recent price of the firm is $14.3. Our model computes the value of Dr Reddys Laboratories from reviewing the firm fundamentals such as Shares Owned By Institutions of 14.22 %, return on asset of 0.1, and Current Valuation of 11.85 B as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Dr Reddys' valuation include:
Price Book 3.2996 | Enterprise Value 11.9 B | Enterprise Value Ebitda 11.1519 | Price Sales 0.0401 | Forward PE 17.7305 |
Fairly Valued
Today
Please note that Dr Reddys' price fluctuation is very steady at this time. Calculation of the real value of Dr Reddys Laboratories is based on 3 months time horizon. Increasing Dr Reddys' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Dr Reddys is currently traded on the exchange, buyers and sellers on that exchange determine the market value of RDY Stock. However, Dr Reddys' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14.3 | Real 14.67 | Target 70.11 | Hype 14.3 | Naive 14.42 |
The intrinsic value of Dr Reddys' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Dr Reddys' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Dr Reddys Laboratories helps investors to forecast how RDY stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Dr Reddys more accurately as focusing exclusively on Dr Reddys' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Dr Reddys' intrinsic value based on its ongoing forecasts of Dr Reddys' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Dr Reddys' closest peers.
Dr Reddys Cash |
|
RDY Valuation Trend
Analysing the historical paterns of Dr Reddys' enterprise value and its market capitalization is a good way to estimate and gauge the value of Dr Reddys Laboratories over time and is usually enough for investors to make rational market timing decisions.
Dr Reddys Total Value Analysis
Dr Reddys Laboratories is at this time forecasted to have company total value of 11.85 B with market capitalization of 12.02 B, debt of 20.02 B, and cash on hands of 2.93 B. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Dr Reddys fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.85 B | 12.02 B | 20.02 B | 2.93 B |
Dr Reddys Investor Information
About 14.0% of the company shares are owned by institutional investors. The book value of Dr Reddys was at this time reported as 366.54. The company last dividend was issued on the 30th of July 2024. Dr Reddys Laboratories had 5:1 split on the 5th of November 2024. Based on the key indicators related to Dr Reddys' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, Dr Reddys Laboratories is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.25 | 0.2426 |
|
| |||||
| Total Cash From Operating Activities | 47.7 B | 45.4 B |
|
| |||||
| Operating Income | 71.1 B | 67.7 B |
|
|
Dr Reddys Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Dr Reddys has an asset utilization ratio of 72.04 percent. This suggests that the Company is making $0.72 for each dollar of assets. An increasing asset utilization means that Dr Reddys Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.Dr Reddys Ownership Allocation
Dr Reddys Laboratories secures a total of 833.07 Million outstanding shares. About 85.78 % of Dr Reddys outstanding shares are held by general public with 14.22 (percent) by institutions. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.Dr Reddys Profitability Analysis
The company reported the last year's revenue of 279.16 B. Total Income to common stockholders was 55.68 B with profit before taxes, overhead, and interest of 113.84 B.Dr Reddys Past Distributions to stockholders
About Dr Reddys Valuation
Our relative valuation model uses a comparative analysis of Dr Reddys. We calculate exposure to Dr Reddys's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Dr Reddys's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 163.6 B | 171.8 B | |
| Pretax Profit Margin | 0.26 | 0.27 | |
| Operating Profit Margin | 0.24 | 0.25 | |
| Net Profit Margin | 0.20 | 0.21 | |
| Gross Profit Margin | 0.59 | 0.43 |
Dr Reddys Quarterly Retained Earnings |
|
A single share of Dr Reddys represents a small ownership stake in the entity. As a stockholder of RDY, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Dr Reddys Dividends Analysis For Valuation
Please note that Dr Reddys has scaled down on payment of dividends at this time. Retained Earnings is likely to rise to about 278.5 B in 2024, whereas Earnings Yield is likely to drop 0.05 in 2024.
There are various types of dividends Dr Reddys can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of RDY shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Dr Reddys Laboratories directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When RDY pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Dr Reddys by the value of the dividends paid out.
Dr Reddys Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 166.7 M | |
| Quarterly Earnings Growth Y O Y | -0.153 | |
| Forward Price Earnings | 17.7305 |
Dr Reddys Current Valuation Indicators
Valuation refers to the process of determining the present value of Dr Reddys Laboratories and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value RDY we look at many different elements of the entity such as RDY's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Dr Reddys, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Dr Reddys' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Dr Reddys' worth.Additional Tools for RDY Stock Analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.